Toward a more comprehensive assessment of depression remission: The Remission Evaluation and Mood Inventory Tool (REMIT)

General Hospital Psychiatry

Volumn 33, Issue 3, 2011, Pages 279-286

  Nease, Donald E ^a   Aikens, James E ^a   Klinkman, Michael S ^a   Kroenke, Kurt ^b   Sen, Ananda ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Depression; Measurement based care; Primary care; Remission

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT HEALTH QUESTIONNAIRE 8; PRIMARY MEDICAL CARE; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RELIABILITY; REMISSION; REMISSION EVALUATION AND MOOD INVENTORY TOOL; SELF REPORT; SEX RATIO; VALIDATION STUDY;

ADULT; CROSS-SECTIONAL STUDIES; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; INDIANA; MALE; MICHIGAN; PRIMARY HEALTH CARE; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 79956146963     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2011.03.002     Document Type: Article

References (31)

1. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289(23):3095-3105.
2. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51(1):8-19.
3. Barrett J.E., Barrett J.A., Oxman T.E., Gerber P.D. The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 1988, 45(12):1100-1106.
4. Katon W. The epidemiology of depression in medical care. Int J Psychiatry Med 1987, 17(1):93-112.
5. Leon A.C., Olfson M., Broadhead W.E., Barrett J.E., Blacklow R.S., Keller M.B., et al. Prevalence of mental disorders in primary care - implications for screening. Arch Fam Med 1995, 4(10):857-861.
6. Mojtabai R., Olfson M. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. J Clin Psychiatry 2008, 69(7):1064-1074.
7. Depression Guideline P. Depression in primary care: volume 2. Treatment of major depression. Clinical practice guideline, Number 5. (AHCPR Publication No. 93-0551) 1993, US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Rockville (MD).
8. Trivedi M.H. Treating depression to full remission. J Clin Psychiatry 2009, 70(1):e01.
9. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6(4):278-296.
10. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16(9):606-613.
11. Zimmerman M., Chelminski I., Posternak M.A. Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. Am J Psychiatry 2005, 162(7):1370-1372.
12. Zimmerman M., Mattia J.I., Posternak M.A. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am J Psychiatry 2002, 159(3):469-473.
13. Katz M.M. Clinical trials of antidepressants: time to shift to a new model. J Clin Psychopharmacol 2008, 28(4):468-470.
14. Keller M.B. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA 2003, 289(23):3152-3160.
15. Keller M.B. Remission versus response: the new gold standard of antidepressant care. J Clin Psychiatry 2004, 65(Suppl 4):53-59.
16. Zimmerman M., McGlinchey J.B., Posternak M.A., Friedman M., Attiullah N., Boerescu D. How should remission from depression be defined? The depressed patient's perspective. Am J Psychiatry 2006, 163(1):148-150.
17. Riedel M., Möller H.-J., Obermeier M., et al. Response and remission criteria in major depression-a validation of current practice. J Psychiatr Res 2010, 44(15):1063-1068.
18. Rush A.J., Trivedi M.H., Ibrahim H.M., Carmody T.J., Arnow B., Klein D.N., et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003, 54(5):573-583.
19. Kroenke K., West S.L., Swindle R., Gilsenan A., Eckert G.J., Dolor R., et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA 2001, 286(23):2947-2955.
20. Aikens J.E., Kroenke K., Nease D.E., Klinkman M.S., Sen A. Trajectories of improvement for six depression-related outcomes. Gen Hosp Psychiatry 2008, 30(1):26-31.
21. Aikens J.E., Kroenke K., Swindle R.W., Eckert G.J. Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. Gen Hosp Psychiatry 2005, 27(4):229-236.
22. Dube P., Kroenke K., Bair M.J., Theobald D., Williams L.S. The P4 screener: evaluation of a brief measure for assessing potential suicidal risk in 2 randomized effectiveness trials of primary care and oncology patients. Primary Care Companion J Clin Psychiatry 2010, 12(6):e1-e8.
23. Kroenke K., Spitzer R.L. The PHQ-9: a new depresion and diagnostic severity measure. Psychiatr Ann 2002, 32:509-521.
24. Kroenke K., Spitzer R.L., Williams J.B., Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 2010, 32(4):345-359.
25. Trivedi M.H. Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission. J Clin Psychiatry 2009, 70(Suppl 6):26-31.
26. Trivedi M.H. Remission of depression and the Texas Medication Algorithm Project. Manag Care Interface 2003, (Suppl B):9-13.
27. Trivedi M.H., Daly E.J. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend 2007, 88(Suppl 2):S61-S71.
28. Katzelnick D.J., Von Korff M., Chung H., Provost L.P., Wagner E.H. Applying depression-specific change concepts in a collaborative breakthrough series. Jt Comm J Qual Patient Saf 2005, 31(7):386-397.
29. Nease D.E., Nutting P.A., Dickinson W.P., Bonham A.J., Graham D.G., Gallagher K.M., et al. Inducing sustainable improvement in depression care in primary care practices. Jt Comm J Qual Patient Saf 2008, 34(5):247-255.
30. Helzer J.E., Kraemer H.C., Krueger R.F. The feasibility and need for dimensional psychiatric diagnoses. Psychol Med 2006, 36(12):1671-1680.
31. American Psychiatric Association Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th ed.